Key Insights

Highlights

Treatment Research

1 treatments under study, led by Regular Treatment For Syphilis

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

Trial Status

Terminated1

Clinical Trials (1)

Research Network

Common Treatments

  • Regular Treatment For Syphilis1

Active Sponsors

  • Ottawa Hospital Research Institute1
  • CIHR Canadian HIV Trials Network1

Top Investigators

Related Conditions

  • Secondary Syphilis1
  • Primary Syphilis1
  • Syphilis1

Activity Timeline